studies as well as prevalence of renal biopsy have contributed to elucidate the pathogenic mechanism of glomerular nephritis. Renal biopsy plays an important role to combine clinical findings and mor- Membranoproliferative glomerulonephretis (MPGN) manifests thickening of the basement membrane of glomeruli and hypertrophy of the mesangium cell. MPGNhas three morphological types. Type I which the basement membraneof the glomeruli is thickened irregularly accompanied by mesangial interposition and type II which the basement membrane is thickened accompanied by dense deposits. Type III which is a mixed type of type I and type II. Lowcomplement titer is observed in MPGN, the sameas in acute glomerulonephritis, also type II manifests an appearance ofC3nephritic factor (C3NeF) as compared with type I. This C3NeFis considered as an autoantibody to IgG ofC3 convertase (C3bBb) which is produced by the alternative pathway.
In our experience, the diagnosis of focal glomerulosclerosis (FGS) is difficult depending on the site or count of the glomeruli taken by biopsy on account of the lesional focus of FGSis located at deep in the juxtamedullary region. In such a case, the differential diagnosis from minimal change group is especially difficult. There are two hypothesis regarding pathological factors of FGS. The first hypothesis is that some of the capillary of the glomerulus will be obstructed by etiological factors (such as enhancement of local coagulation?) in minimal change group as time goes on. The second hypothesis is that FGSwill be quite a different disease from the minimal change group and will be caused spon taneously. In many of FGS, predominant precipitation of IgM, C3 and fibrinogen in the sclerosis lesion was observed by the immuno-fluorescence method, but IgG and IgA are not observed. Frorr the findings of the precipitated picture by the immuno-enzymatic electron microscopy for IgG, FGS cannot be considered as immunecomplex disease. For the treatment of glomerular diseases, corticosteroids are most widely used, and pulse therapy immuno-suppressant therapy, anti-coagulant therapy, anti-platelet drug therapy and non-steroida! anti-in-flammatory drug therapy are also conducted. It is thought that some patients with progressive glomerulonephritis and intractable nephrotic syndrome well respond to pulse therapy. It is alsc thought that r-grobulin therapy is effective for immune complex nephritis. At present, gebexate emsilate has property of multiprotease inhibitor and acts on the caogulantfibrino lytic system, platelei function and kinin-kallikrein system is also applied.
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